A carregar...
Sodium-Glucose Linked Transporter-2 Inhibitors in Chronic Kidney Disease
SGLT2 inhibitors are new antihyperglycaemic agents whose ability to lower glucose is directly proportional to GFR. Therefore, in chronic kidney disease (CKD) the blood glucose lowering effect is reduced. Unlike many current therapies, the mechanism of action of SGLT2 inhibitors is independent of ins...
Na minha lista:
| Publicado no: | ScientificWorldJournal |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4345065/ https://ncbi.nlm.nih.gov/pubmed/25785281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/317507 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|